Vanguard Mega Cap Value Index Fund Inst (VMVLX)
252.22
-1.13
(-0.45%)
USD |
Jun 04 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.06% | 9.067B | 2.33% | 13.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 1.094B | 10.55% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the performance of a benchmark index that measures the investment return of the largest-capitalization value stocks in the United States. The Fund employs an indexing investment approach designed to track the performance of the CRSP US Mega Cap Value Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Large-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | Vanguard |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
4
-687.38M
Peer Group Low
328.43M
Peer Group High
1 Year
% Rank:
4
1.094B
-11.65B
Peer Group Low
6.855B
Peer Group High
3 Months
% Rank:
4
-3.235B
Peer Group Low
1.239B
Peer Group High
3 Years
% Rank:
4
-26.09B
Peer Group Low
10.76B
Peer Group High
6 Months
% Rank:
4
-6.296B
Peer Group Low
3.113B
Peer Group High
5 Years
% Rank:
6
-34.65B
Peer Group Low
11.55B
Peer Group High
YTD
% Rank:
4
-4.177B
Peer Group Low
3.066B
Peer Group High
10 Years
% Rank:
3
-39.59B
Peer Group Low
10.96B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of June 05, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.05% |
| Stock | 99.90% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.05% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Berkshire Hathaway Inc | 4.36% | 488.97 | -0.41% |
| JPMorgan Chase & Co | 4.25% | 261.73 | -0.94% |
| Exxon Mobil Corp | 2.85% | 102.08 | -0.22% |
| Walmart Inc | 2.67% | 97.97 | -1.39% |
| Procter & Gamble Co | 2.37% | 163.04 | -1.75% |
| UnitedHealth Group Inc | 2.35% | 295.56 | -1.60% |
| Johnson & Johnson | 2.34% | 153.93 | 0.46% |
| The Home Depot Inc | 2.23% | 369.72 | -0.72% |
| AbbVie Inc | 2.14% | 187.93 | 0.31% |
| Berkshire Hathaway Inc | 1.71% | 732108.3 | -0.77% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.05% |
| Administration Fee | 62.00K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 5.00M None |
| Minimum Subsequent Investment | 1.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the performance of a benchmark index that measures the investment return of the largest-capitalization value stocks in the United States. The Fund employs an indexing investment approach designed to track the performance of the CRSP US Mega Cap Value Index. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Large-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | Vanguard |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (6-4-25) | 2.26% |
| 30-Day SEC Yield (4-30-25) | 2.25% |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 22.58 |
| Weighted Average Price to Sales Ratio | 3.591 |
| Weighted Average Price to Book Ratio | 6.076 |
| Weighted Median ROE | 41.07% |
| Weighted Median ROA | 7.28% |
| ROI (TTM) | 13.44% |
| Return on Investment (TTM) | 13.44% |
| Earning Yield | 0.0538 |
| LT Debt / Shareholders Equity | 1.904 |
As of April 30, 2025
Growth Metrics
| EPS Growth (1Y) | 13.60% |
| EPS Growth (3Y) | 3.59% |
| EPS Growth (5Y) | 7.44% |
| Sales Growth (1Y) | 4.67% |
| Sales Growth (3Y) | 5.90% |
| Sales Growth (5Y) | 6.23% |
| Sales per Share Growth (1Y) | 11.50% |
| Sales per Share Growth (3Y) | 7.43% |
| Operating Cash Flow - Growth Ratge (3Y) | 1.01% |
As of April 30, 2025
Fund Details
| Key Dates | |
| Inception Date | 3/5/2008 |
| Last Annual Report Date | 8/31/2024 |
| Last Prospectus Date | 12/20/2024 |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | -- |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Synthetic Replication Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:VMVLX", "name") |
| Broad Asset Class: =YCI("M:VMVLX", "broad_asset_class") |
| Broad Category: =YCI("M:VMVLX", "broad_category_group") |
| Prospectus Objective: =YCI("M:VMVLX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |